How can i help you?

Blolgs

BRCA Testing for Breast Cancer: Who Needs It?

BRCA Testing for Breast Cancer: Who Needs It?

BRCA Testing for Breast Cancer: Who Needs It?

BRCA Testing for Breast Cancer: Who Needs It?
site.CALENDAR_IMAGE_ALT
06/10/2026

BRCA and Breast Cancer: Who Needs Genetic Testing and What Do the Results Mean?

Not everyone needs BRCA testing, and having breast cancer in the family does not automatically mean the cancer is hereditary. However, genetic testing can be extremely important in selected situations because it may affect cancer risk assessment, family members, future screening and sometimes breast cancer treatment itself.

A positive BRCA result also does not mean that a person currently has cancer or will inevitably develop it. It means that a harmful inherited gene change has been identified that increases the risk of certain cancers. [1]

Quick answers:
Important: Genetic testing is not simply a positive-or-negative laboratory test. Its interpretation depends on personal history, family history, the type of test performed and the exact genetic finding. Genetic counseling or evaluation by a clinician experienced in cancer genetics can be important.
Contents

Is breast cancer hereditary?

Breast cancer can be hereditary, but most breast cancers are not caused directly by an inherited cancer-predisposition variant.

The American Cancer Society estimates that about 5–10% of breast cancers are hereditary. [6]

BRCA1 and BRCA2 are among the best-known inherited breast cancer susceptibility genes, but they are not the only ones.

Other genes such as PALB2, TP53, PTEN and CDH1 can also be clinically important, which is why a multigene panel may be more appropriate than BRCA-only testing in some people. [2]

Does breast cancer in the family automatically mean hereditary cancer?

No.

Family patterns become more suggestive of inherited cancer risk when they include:

[1] [3]

What are BRCA1 and BRCA2?

BRCA1 and BRCA2 are normal genes that produce proteins involved in repairing damaged DNA. [1]

Problems arise when a person inherits a harmful change, known as a pathogenic or likely pathogenic variant, in one of these genes.

According to the National Cancer Institute, more than 60% of women who inherit a harmful BRCA1 or BRCA2 change may develop breast cancer during their lifetime. [1]

This is a substantial increase in risk, but it is not a guarantee that cancer will occur.

BRCA-positive means increased risk, not a cancer diagnosis.

Some people inherit harmful BRCA variants and never develop cancer.

Who should consider BRCA testing?

Testing criteria can vary among health systems and professional guidelines, and the same criteria do not apply to people with cancer and people who have never had cancer.

For people newly diagnosed with breast cancer

The ASCO–Society of Surgical Oncology guideline recommends offering BRCA1/2 testing to all patients newly diagnosed with breast cancer at age 65 or younger. [2]

For patients older than 65, testing should also be offered in selected situations, including when:

Testing may also be important for recurrent breast cancer when PARP inhibitor therapy is being considered and for patients who develop a second primary breast cancer. [2]

Why test if breast cancer has already been diagnosed?

A germline test can provide information that may affect several areas of care:

[1] [2]

For a broader explanation of treatment decisions, read: Breast Cancer Treatment: How Does the Plan Change by Stage and Subtype?

What if I do not have cancer but have a family history?

Not every family history requires genetic testing, but a genetics assessment becomes more important when there is:

[1] [3]

Who should be tested first in a family?

When possible, the National Cancer Institute recommends that testing for an inherited cancer syndrome begin with a relative who has had cancer. [3]

If a pathogenic variant is identified in the affected relative, other relatives can then be tested specifically for that variant.

Book an appointment at Mouwasat Hospital

Can BRCA be inherited from the mother or father?

Either parent.

A harmful inherited BRCA variant can come from the mother or the father, so cancer history on the father's side of the family is just as relevant to genetic risk assessment.

If a parent carries a BRCA mutation, each child has a 50% chance of inheriting it. [5]

If my mother had breast cancer, will I develop it too?

Not necessarily.

Her breast cancer might not be hereditary. Even if she carries a BRCA variant, each child has a 50% chance of inheriting it, and inheriting the variant still does not guarantee cancer.

How is BRCA testing done?

Inherited BRCA testing is commonly performed using:

An inherited germline variant is present throughout the body's cells, which is why blood or saliva can be used. [1]

Is BRCA1/2 testing always enough?

No.

A clinician may recommend a multigene panel when the personal or family history suggests that genes other than BRCA1 and BRCA2 may be relevant. [2]

What about direct-to-consumer BRCA tests?

Some consumer tests examine only a limited number of known BRCA variants.

A negative result from such a test therefore may not rule out other clinically important BRCA variants. [1] [4]

What is the difference between germline and tumour testing?

Test What does it assess? Does it prove inheritance?
Germline testing Inherited variants present throughout the body. Yes, when a pathogenic inherited variant is identified.
Tumour / somatic testing Genetic changes within the cancer itself that may help guide treatment. Not necessarily.

A BRCA alteration found in a tumour may either be inherited or have arisen only in the tumour during a person's lifetime.

Therefore, if tumour testing identifies a harmful BRCA change, germline testing may be considered to determine whether it was inherited. [1] [3]

A BRCA mutation found in a tumour does not automatically mean a patient's children inherited it.

Germline testing is needed to clarify whether the finding is inherited.

What do BRCA test results mean?

Positive / pathogenic variant

A positive result means that a harmful or likely harmful genetic variant has been identified.

It can indicate:

A positive result does not predict exactly whether or when cancer will occur. [1]

Negative

The meaning depends on context.

If a specific pathogenic variant is already known in the family and a relative tests negative for that exact variant, this is a true negative: the person did not inherit that familial variant. [1]

If no familial variant has been identified, however, a negative result can be uninformative. Family history may still indicate increased risk, and another genetic cause may remain possible. [3]

VUS – Variant of Uncertain Significance

A VUS is a genetic change for which there is not yet enough evidence to classify it as harmful or benign.

A VUS is not a positive pathogenic result.

The ASCO–SSO guideline states that variants of uncertain significance should not alter management. [2]

Many VUS findings are eventually reclassified as benign as more scientific data become available. [1]

What does a positive result mean for the family?

If a germline BRCA variant is confirmed, blood relatives may also carry it.

Parents, siblings and adult children are usually among the closest relatives considered first, followed by other blood relatives based on the family tree.

Each child of a BRCA carrier has a 50% chance of inheriting the variant. [5]

Should children be tested?

BRCA testing is generally not recommended for children younger than 18 because BRCA-associated cancers are extremely uncommon in childhood and childhood management usually does not change based on the result. [1]

What happens after a positive BRCA result?

Management is individualized.

Depending on whether a person already has cancer, age, family history and other factors, options may include:

[1]

For more on breast screening, read: Mammogram Breast Cancer Screening: When Should You Start?

Find a doctor at Mouwasat Hospital

Does a positive BRCA result mean both breasts must be removed?

No.

Risk-reducing mastectomy can be discussed as one option for some BRCA carriers, but it is not an automatic requirement.

The decision can depend on:

The National Cancer Institute lists enhanced screening and risk-reducing surgery among the options available to people with inherited harmful BRCA variants. [1]

Can BRCA change breast cancer treatment?

Yes, in selected situations.

BRCA-deficient cancer cells have impaired DNA repair, which can make certain treatment strategies particularly useful.

One important example is:

PARP inhibitors.

These targeted treatments can be used in specific cancers with harmful BRCA changes. [1]

However, a BRCA result alone does not determine treatment. The decision also depends on stage, whether the variant is germline or somatic, tumour subtype, previous therapies and approved treatment indications.

This is why BRCA testing may matter even without a striking family history.

For some patients with breast cancer, the result can have direct treatment implications as well as implications for relatives.

What is the link between BRCA1 and triple-negative breast cancer?

Breast cancers in people with inherited harmful BRCA1 changes are more likely to be triple-negative than breast cancers in the general population. [1]

But not every triple-negative cancer is caused by BRCA, and not every BRCA-associated cancer is triple-negative.

Learn more: Breast Cancer Types and Stages: ER, PR, HER2 and Triple-Negative Disease.

Does BRCA matter for men?

Yes.

BRCA variants can be inherited and passed on by men as well as women.

BRCA2 in particular is associated with an increased risk of male breast cancer and prostate cancer, while BRCA variants can also be associated with pancreatic cancer risk. [1]

Male breast cancer itself is an important reason to consider hereditary cancer testing. [3]

Read: Male Breast Cancer: Signs That Can Be Missed and When to Seek Evaluation.

Does BRCA testing detect breast cancer early?

No.

BRCA testing detects inherited cancer susceptibility. It does not look for a tumour.

Breast cancer screening and diagnosis use tests such as mammography, breast MRI in selected high-risk people, and diagnostic imaging when symptoms or abnormal findings are present.

Does a negative BRCA test mean I no longer need breast screening?

No.

Most breast cancers are not caused by an inherited BRCA variant, so routine or risk-based screening remains important even when BRCA testing is negative.

Frequently asked questions about BRCA

What is a BRCA test?

It is a genetic test that looks for harmful changes in BRCA1 and BRCA2 that can increase the risk of breast, ovarian and some other cancers.

Does a BRCA test tell me if I have cancer?

No. It identifies genetic susceptibility rather than detecting a breast tumour.

Can BRCA be inherited from the father?

Yes. BRCA can be inherited from either parent.

If my parent has a BRCA mutation, what is my chance of inheriting it?

Each child has a 50% chance of inheriting the variant. [5]

If my sister has breast cancer, do I automatically need testing?

Not automatically. The age at diagnosis, other cancers in the family and whether a pathogenic variant has already been found all affect whether testing is appropriate.

What does BRCA-positive mean?

It means a harmful or likely harmful BRCA variant has been identified. It indicates increased cancer risk but does not guarantee that cancer will develop.

What does a negative BRCA test mean?

Its significance depends on whether a known familial variant exists. A true negative for a known family mutation is different from a negative test in a family where no genetic cause has yet been identified.

What is a VUS?

A variant of uncertain significance is a genetic change that cannot yet be classified as harmful or benign. It should not be treated as a pathogenic result. [2]

Does everyone with BRCA develop breast cancer?

No. Risk is substantially increased, but some carriers never develop cancer.

Can BRCA affect breast cancer treatment?

Yes. In selected patients, BRCA status may affect eligibility for targeted treatments such as PARP inhibitors and can contribute to longer-term surgical and risk-management discussions.

Key takeaway

A family history of breast cancer does not automatically mean that BRCA is present, and most breast cancers are not hereditary.

However, BRCA testing can be highly valuable when personal or family history suggests inherited cancer risk, and it is now offered more broadly to many people already diagnosed with breast cancer because the result can also influence treatment.

A positive result means increased risk, not inevitable cancer. A negative result does not always mean average risk, and a VUS should not be treated as a confirmed harmful mutation.

BRCA can be inherited from either the mother or the father, making the result relevant to both women and men within a family.

References

  1. National Cancer Institute – BRCA Gene Changes: Cancer Risk and Genetic Testing
  2. ASCO–Society of Surgical Oncology – Germline Testing in Patients With Breast Cancer
  3. National Cancer Institute – Genetic Testing for Inherited Cancer Risk
  4. American Cancer Society – Genetic Counseling and Testing for Breast Cancer Risk
  5. CDC – Talking to Family About Your BRCA Gene Mutation
  6. American Cancer Society – Breast Cancer Risk Factors You Cannot Change




Next
Prev


Mouwasat Medical Dammam Dispensary in '75, evolved into LLC managing multiple facilities in '97 under same registration.

Contact Information

Unified Number:
+966 920 004 477